The B cell is the initiating antigen-presenting cell in peripheral lymph nodes
- PMID: 3100626
The B cell is the initiating antigen-presenting cell in peripheral lymph nodes
Abstract
We have examined the role of B cells in antigen presentation in lymph nodes in several ways. We found that mice depleted of B lymphocytes via chronic injection of anti-mu-chain antibody do not mount peripheral lymph node T cell proliferative responses to normally immunogenic doses of antigen. Depletion of B cells by passage of immune lymph node cells over anti-immunoglobulin columns early after immunization depletes antigen-presenting function from draining lymph nodes, and this function can be restored by using B cells or splenic adherent cells to allow the remaining T cells to proliferate. Lymph node B cells present antigen very effectively to lines of antigen-specific T cells. However, unfractionated lymph node cells from anti-mu-treated mice present very poorly, if at all, whereas unfractionated spleen cells from the same mice do present antigen. This is in keeping with our previous finding that helper T cell function in the spleen is normal in B cell-deprived mice. Finally, when mice homozygous for the lymphoproliferative gene lpr are treated chronically with anti-mu-chain antibody, lymphadenopathy is greatly retarded, suggesting a role for B cells in the massive proliferation of T cells in this syndrome. From this analysis, it would appear that the initiating antigen-presenting cell in the lymph node is a B lymphocyte, and that B lymphocytes in lymph nodes may be distinct from those in the spleen. It is of interest that these results also suggest that the lymph node lacks an antigen-presenting cell that is found in the spleen, perhaps the dendritic cell.
Similar articles
-
T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.J Immunol. 1987 May 1;138(9):2848-56. J Immunol. 1987. PMID: 2952725
-
Differential responses of B cells from the spleen and lymph node to TNP-Ficoll.J Immunol. 1988 May 1;140(9):2925-30. J Immunol. 1988. PMID: 3129503
-
Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.Behring Inst Mitt. 1983 May;(72):107-16. Behring Inst Mitt. 1983. PMID: 6242330
-
Immunological functions and in vivo cell-cell interactions of T cells in the spleen.Crit Rev Immunol. 1992;11(6):337-80. Crit Rev Immunol. 1992. PMID: 1388710 Review.
-
Antigen presentation by B lymphocytes to CD4+ T lymphocytes in vivo: importance for B lymphocyte and T lymphocyte activation.Semin Immunol. 1992 Aug;4(4):247-55. Semin Immunol. 1992. PMID: 1356502 Review.
Cited by
-
Design of CD40 agonists and their use in growing B cells for cancer immunotherapy.Int Rev Immunol. 2012 Aug;31(4):279-88. doi: 10.3109/08830185.2012.703272. Int Rev Immunol. 2012. PMID: 22804572 Free PMC article. Review.
-
Antigen presenting cells.Immunol Res. 1989;8(2):98-117. doi: 10.1007/BF02919073. Immunol Res. 1989. PMID: 2659691 Review.
-
B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris.Infect Immun. 2001 Jun;69(6):3860-8. doi: 10.1128/IAI.69.6.3860-3868.2001. Infect Immun. 2001. PMID: 11349052 Free PMC article.
-
Polarized helper-T-cell responses against Leishmania major in the absence of B cells.Infect Immun. 1999 Jan;67(1):266-70. doi: 10.1128/IAI.67.1.266-270.1999. Infect Immun. 1999. PMID: 9864225 Free PMC article.
-
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.Infect Immun. 1992 Feb;60(2):584-9. doi: 10.1128/iai.60.2.584-589.1992. Infect Immun. 1992. PMID: 1730492 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials